Countries | Year of survey | Sample size | Prevalence of full Immunisation | P value | |
Urban prev. (95% CI) | Rural prev. (95% CI) | ||||
Benin | 2017/2018 | 2382 | 60.2 (56.1 to 64.1) | 53.1 (49.7 to 56.4) | 0.008 |
Burundi | 2016 | 1236 | 78.7 (67.3 to 87.0) | 77.8 (74.8 to 80.5) | 0.862 |
Democratic Republic of Congo | 2013/2014 | 1661 | 42.3 (36.4 to 48.5) | 22.8 (18.7 to 27.6) | <0.001 |
Ethiopia | 2016 | 1813 | 49.0 (36.4 to 61.7) | 12.8 (10.2 to 16.1) | <0.001 |
Gabon | 2012 | 726 | 3.9 (2.2 to 6.6) | 9.0 (5.9 to 13.6) | 0.013 |
Ghana | 2014 | 562 | 67.5 (60.1 to 74.1) | 55.6 (48.1 to 62.9) | 0.024 |
Gambia | 2013 | 715 | 65.5 (56.1 to 73.9) | 84.9 (81.0 to 88.2) | <0.001 |
Guinea | 2018 | 717 | 25.5 (18.7 to 33.6) | 17.2 (13.6 to 21.5) | 0.041 |
Kenya | 2014 | 1815 | 69.3 (62.1 to 75.7) | 54.9 (51.3 to 58.5) | <0.001 |
Liberia | 2013 | 665 | 49.2 (37.3 to 61.2) | 43.3 (37.2 to 49.5) | 0.394 |
Lesotho | 2014 | 109 | 87.8 (70.2 to 95.7) | 65.9 (52.3 to 77.4) | 0.033 |
Mali | 2018 | 1803 | 44.5 (37.7 to 51.6) | 31.4 (27.7 to 35.4) | 0.001 |
Malawi | 2015/2016 | 1073 | 56.0 (43.8 to 67.5) | 55.7 (51.6 to 60.0) | 0.961 |
Nigeria | 2018 | 1278 | 45.7 (39.8 to 51.7) | 23.0 (19.5 to 26.9) | <0.001 |
Niger | 2012 | 970 | 71.0 (64.4 to 76.7) | 37.5 (33.1 to 42.0) | <0.001 |
Namibia | 2013 | 404 | 75.5 (66.7 to 82.6) | 84.6 (79.6 to 88.5) | 0.038 |
Sierra Leone | 2013 | 943 | 63.2 (54.5 to 71.2) | 67.5 (62.6 to 72.1) | 0.380 |
Togo | 2013/2014 | 689 | 67.4 (59.5 to 74.4) | 56.5 (49.4 to 63.3) | 0.040 |
Tanzania | 2015/2016 | 2006 | 75.9 (71.7 to 79.6) | 47.6 (43.4 to 51.8) | <0.000 |
Uganda | 2016 | 882 | 54.8 (46.4 to 62.9) | 44.3 (40.4 to 48.3) | 0.026 |
South Africa | 2016 | 289 | 66.9 (56.4 to 75.9) | 68.9 (58.9 to 77.5) | 0.769 |
Zambia | 2013/2014 | 2439 | 56.8 (52.2 to 61.3) | 25.6 (22.9 to 28.6) | <0.001 |
Zimbabwe | 2015 | 1064 | 0.0 | 0.0 | n/a |
Total | 2010–2018 | 26 241 | 52.8 (51.1 to 54.4) | 40.7 (39.7 to 41.7) | <0.001 |
n/a, not applicable.